Codification In subsec. (a), “December 22, 1987” substituted for “the
Effective Date
of this subpart” on authority of
section 323 of Pub. L. 99–660, as amended, set out as an
Effective Date
note under
section 300aa–1 of this title.
Amendments
1993—Subsec. (a). Pub. L. 103–183, § 708(c), inserted “or to any other individual” after “to the legal representatives of any child”. Subsec. (b). Pub. L. 103–183, § 708(a), struck out “by rule” after “revised” in introductory provisions and substituted “and 60” for “, opportunity for a public hearing, and 90” in par. (1). Subsec. (c). Pub. L. 103–183, § 708(b), inserted in introductory provisions “shall be based on available data and information,” after “such materials”, added pars. (1) to (4), and struck out former pars. (1) to (10) which read as follows: “(1) the frequency, severity, and potential long-term effects of the disease to be prevented by the vaccine, “(2) the symptoms or reactions to the vaccine which, if they occur, should be brought to the immediate attention of the health care provider, “(3) precautionary measures legal representatives should take to reduce the risk of any major adverse reactions to the vaccine that may occur, “(4) early warning signs or symptoms to which legal representatives should be alert as possible precursors to such major adverse reactions, “(5) a description of the manner in which legal representatives should monitor such major adverse reactions, including a form on which reactions can be recorded to assist legal representatives in reporting information to appropriate authorities, “(6) a specification of when, how, and to whom legal representatives should report any major adverse reaction, “(7) the contraindications to (and bases for delay of) the administration of the vaccine, “(8) an identification of the groups, categories, or characteristics of potential recipients of the vaccine who may be at significantly higher risk of major adverse reaction to the vaccine than the general population, “(9) a summary of— “(A) relevant Federal recommendations concerning a complete schedule of childhood immunizations, and “(B) the availability of the Program, and “(10) such other relevant information as may be determined by the Secretary.” Subsec. (d). Pub. L. 103–183, § 708(c), (d), in concluding provisions, inserted “or to any other individual” after “to the legal representatives of any child”, substituted “supplemented with visual presentations or oral explanations, in appropriate cases” for “or other written information which meets the requirements of this section”, and struck out “or other information” after “Such materials”. 1992—Subsec. (b)(2). Pub. L. 102–531 substituted “Centers for Disease Control and Prevention” for “Centers for Disease Control”. 1989—Subsec. (c)(9). Pub. L. 101–239 amended par. (9) generally. Prior to amendment, par. (9) read as follows: “a summary of relevant State and Federal laws concerning the vaccine, including information on— “(A) the number of vaccinations required for school attendance and the schedule recommended for such vaccinations, and “(B) the availability of the Program, and”. 1987—Subsec. (a). Pub. L. 100–203 substituted “
Effective Date
of this subpart” for “
Effective Date
of this part”.
Statutory Notes and Related Subsidiaries
Effective Date
of 1989 AmendmentFor applicability of
Amendments
by Pub. L. 101–239 to petitions filed after Dec. 19, 1989, petitions currently pending in which the evidentiary record is closed, and petitions currently pending in which the evidentiary record is not closed, with provision for an immediate suspension for 30 days of all pending cases, see
section 6601(s)(1) of Pub. L. 101–239, set out as a note under
section 300aa–10 of this title.
